BGMS Q3 2024 Earnings Significant EPS Beat Tempered by Revenue Uncertainty PAG Q1 2026 Earnings EPS Beats Estimates by 352 Amid Stable Operations OOMA Q1 2026 Earnings EPS Surpasses Estimates with 786 Beat Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline Sabine Royalty Trust SBR Q3 2009 Earnings EPS Misses Estimates Amid Weaker Energy Prices ATOS Q1 2026 Earnings EPS Surprise of 8223 Highlights Cost Management in ClinicalStage Biotech